Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Palisade Bio (PALI) Interest Expenses (2016 - 2025)

Palisade Bio has reported Interest Expenses over the past 16 years, most recently at $2000.0 for Q4 2025.

  • Quarterly Interest Expenses fell 33.33% to $2000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $10000.0 through Dec 2025, down 16.67% year-over-year, with the annual reading at $10000.0 for FY2025, 16.67% down from the prior year.
  • Interest Expenses was $2000.0 for Q4 2025 at Palisade Bio, down from $5000.0 in the prior quarter.
  • Over five years, Interest Expenses peaked at $1.7 million in Q1 2021 and troughed at $1000.0 in Q1 2022.
  • The 5-year median for Interest Expenses is $3500.0 (2022), against an average of $135666.7.
  • Year-over-year, Interest Expenses surged 66243.54% in 2021 and then tumbled 99.94% in 2022.
  • A 5-year view of Interest Expenses shows it stood at $26000.0 in 2021, then tumbled by 88.46% to $3000.0 in 2022, then soared by 33.33% to $4000.0 in 2023, then fell by 25.0% to $3000.0 in 2024, then tumbled by 33.33% to $2000.0 in 2025.
  • Per Business Quant, the three most recent readings for PALI's Interest Expenses are $2000.0 (Q4 2025), $5000.0 (Q3 2025), and $2000.0 (Q2 2025).